BrCa subtypes are commonly grouped into four categories based on the immunohistochemical expression of hormone receptors: human epidermal growth factor receptor positive (HER2+), progesterone receptor positive (PR+), estrogen receptor positive (ER+), and triple negative (TNBC) [22]. This evidence concerns the gene PGR and invasive breast carcinoma.